Primecap Management’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
Other funds holding LUNG
SCM
ECM
VCM
SCM
Primecap Management's LUNG Position: Q1 2026 in Review
Primecap Management reduced its Pulmonx (LUNG) stake by 0.06% in Q1 2026, selling an estimated $4.63K and leaving 4,724,991 shares worth $6.1M. The position accounts for ﹤0.01% of the portfolio, ranked #271.
Primecap Management first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $159M in Q4 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.
- Primecap Management held 4,724,991 shares of Pulmonx worth $6.1M as of Q1 2026.
- Primecap Management sold 2,800 Pulmonx shares in Q1 2026, an estimated $4.63K.
- Pulmonx made up ﹤0.01% of Primecap Management's portfolio in Q1 2026, its #271 holding.
- Primecap Management first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
- Primecap Management's Pulmonx position peaked at $159M in Q4 2021.
- 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.
Based on Primecap Management's 13F filing for Q1 2026, filed 11 May 2026.